Target intelligence / Profile preview

Red blood cell surface glycocalyx (RBC glycocalyx) (RBC glycocalyx)

Target
RBC glycocalyx
Molecular classification
Glycoprotein, Glycolipid, Proteoglycan, Cell surface layer, Receptor, Other
01

Overview

The red blood cell (RBC) surface glycocalyx is a complex, carbohydrate-rich layer composed of glycoproteins, glycolipids, and proteoglycans that coats the outer membrane of erythrocytes (Reinhart et al., 2017, PMID: 28811248). It plays a critical role in maintaining vascular homeostasis by regulating blood rheology, protecting the cell from mechanical shear stress, and mediating interactions with the vascular endothelium (Tarbell et al., 2014, PMID: 24553300). The layer's high sialic acid content provides a negative charge that prevents RBC aggregation and maintains the exclusion zone between cells (Neu et al., 2008, PMID: 18234353). In various pathological states such as sepsis, diabetes, and malaria, the glycocalyx can become degraded or shed, leading to impaired microcirculation and increased cell adhesion (Puchulu-Campanella et al., 2013, PMID: 23293137). Specific components like glycophorins serve as essential receptors for Plasmodium falciparum invasion, making them significant targets for anti-malarial strategies (Cowman et al., 2017, PMID: 28414331). Therapeutic strategies often focus on preserving or restoring this layer using glycosaminoglycan mimetics like sulodexide to improve oxygen delivery and reduce inflammatory complications (Broekhuizen et al., 2010, PMID: 20466834). Additionally, stabilizing the glycocalyx with albumin or inhibiting shedding enzymes like matrix metalloproteinases represents a promising avenue for treating microvascular disorders (Alphonsus et al., 2014, PMID: 24809438).

Other names
Erythrocyte glycocalyxRBC surface coatErythrocyte surface layerRBC pericellular matrix
02

Mechanism of action

Restoration of glycocalyx thickness and integrity through the exogenous supply of glycosaminoglycans, inhibition of enzymatic shedding by matrix metalloproteinases (MMPs) or hyaluronidase, and blocking of pathogen-receptor interactions on the cell surface (e.g., blocking Plasmodium EBA-175 binding to Glycophorin A) (Broekhuizen et al., 2010, PMID: 20466834; Cowman et al., 2017, PMID: 28414331).

03

Biological functions

Cell-cell interactionHemodynamicsProtection from shear stressRegulation of vascular resistanceBarrier functionBlood group antigen presentationMechanotransductionSignal transduction
04

Disease associations

MalariaSepsisDiabetes mellitusSickle cell diseaseCardiovascular diseaseInflammationPreeclampsiaInfection
05

Safety considerations

Risk of systemic anticoagulation when using heparinoid-based therapies (Lauver et al., 2014, PMID: 24412451)Potential for immune-mediated thrombocytopenia with heparin-like agentsOff-target effects on endothelial glycocalyx leading to altered vascular permeabilityPotential interference with blood group antigen detection during transfusion medicine (Reinhart et al., 2017, PMID: 28811248)
06

Interacting drugs

Sulodexide

5 more in the full profile.

07

Biomarkers

Syndecan-1 (marker of shedding) (Puskarich et al., 2016, PMID: 26836563)Heparan sulfate levelsHyaluronan concentrationSialic acid content on RBC surfaceRBC deformability

Beyond the preview

Go deeper on Red blood cell surface glycocalyx (RBC glycocalyx) (RBC glycocalyx).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Red blood cell surface glycocalyx (RBC glycocalyx) (RBC glycocalyx).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call